Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Larotrectinib sulfate by Bayer for Sarcomas: Likelihood of Approval
Larotrectinib sulfate is under clinical development by Bayer and currently in Phase II for Sarcomas. According to GlobalData, Phase II...